Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Anika Therapeutics
(NQ:
ANIK
)
24.99
-0.29 (-1.15%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Anika Therapeutics
< Previous
1
2
Next >
ANIK Stock Earnings: Anika Therapeutics Beats EPS, Misses Revenue for Q2 2024
August 08, 2024
ANIK stock results show that Anika Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Peeling Back The Layers: Exploring Anika Therapeutics Through Analyst Insights
May 29, 2024
Via
Benzinga
ANIK Stock Earnings: Anika Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 08, 2024
ANIK stock results show that Anika Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Anika Therapeutics: Q4 Earnings Insights
March 13, 2024
Via
Benzinga
Earnings Outlook For Anika Therapeutics
March 12, 2024
Via
Benzinga
Airbnb, Blackstone Rise On News They'll Join S&P 500 Index
September 02, 2023
ABNB and BX will join Sept. 18 as part of a quarterly rebalancing.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Recap: Anika Therapeutics Q1 Earnings
May 09, 2023
Via
Benzinga
Anika Therapeutics Earnings Preview
March 03, 2023
Via
Benzinga
Earnings Scheduled For March 13, 2024
March 13, 2024
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
Via
Benzinga
3 Sorry Penny Stocks to Sell in August Before It’s Too Late
August 22, 2023
As interest rates rise and money becomes more expensive, investors may look to get rid of these penny stocks set to fail.
Via
InvestorPlace
New FDA 510(k) Clearance Expands Anika's Sports Medicine Soft Tissue Portfolio
May 20, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
March 11, 2022
During Friday's session, 198 companies made new 52-week lows. Key Facts About Today's 52-Week Highs And Lows: Alibaba Group Holding (NYSE:BABA) is the largest...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
February 04, 2022
On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap...
Via
Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
August 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 14, 2023
August 14, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
March 07, 2023
Via
Benzinga
7 Stocks to Buy Before the Market Starts to Soar in 2023
November 10, 2022
With the market falling into a bit of disarray, astute investors can leverage this moment to dive into compelling stocks to buy.
Via
InvestorPlace
Anika Therapeutics Cingal Tops Steroid For Osteoarthritis Pain Relief
November 01, 2022
Via
Benzinga
Anika Therapeutics: Q2 Earnings Insights
August 03, 2022
Anika Therapeutics (NASDAQ:ANIK) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 09, 2022
During Wednesday's session, 35 companies made new 52-week lows. 52-Week High And Low Highlights: The company with the largest market cap to set a new 52-week low was...
Via
Benzinga
Anika Therapeutics: Q4 Earnings Insights
March 08, 2022
Anika Therapeutics (NASDAQ:ANIK) reported its Q4 earnings results on Tuesday, March 8, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout
March 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative...
Via
Benzinga
Anika Therapeutics, inc (ANIK) Q3 2021 Earnings Call Transcript
November 05, 2021
ANIK earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Return on Capital Employed Insights for Anika Therapeutics
August 23, 2021
After pulling data from Benzinga Pro it seems like during Q2, Anika Therapeutics (NASDAQ:ANIK) earned $9.18 million, a 629.73% increase from the preceding quarter. Anika...
Via
Benzinga
Anika Therapeutics, inc (ANIK) Q2 2021 Earnings Call Transcript
August 06, 2021
ANIK earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Earnings Scheduled For March 8, 2022
March 08, 2022
Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •...
Via
Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
March 06, 2022
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 03, 2022
On Thursday, 105 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows And Highs: Meta Platforms (NASDAQ:FB) was the biggest company on...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2021
November 16, 2021
Upgrades According to Maxim Group, the prior rating for VirTra Inc (NASDAQ:
Via
Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.